- Home
- INTZ vs STTK Comparison
INTZ vs STTK Comparison
Compare INTZ & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- STTK
- Stock Information
- Founded
- INTZ 1983
- STTK 2016
- Country
- INTZ United States
- STTK United States
- Employees
- INTZ N/A
- STTK N/A
- Industry
- INTZ Computer Communications Equipment
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- STTK Health Care
- Exchange
- INTZ Nasdaq
- STTK Nasdaq
- Market Cap
- INTZ 32.7M
- STTK 37.6M
- IPO Year
- INTZ 2020
- STTK 2020
- Fundamental
- Price
- INTZ $2.14
- STTK $1.14
- Analyst Decision
- INTZ Buy
- STTK Hold
- Analyst Count
- INTZ 2
- STTK 4
- Target Price
- INTZ $6.25
- STTK $3.00
- AVG Volume (30 Days)
- INTZ 690.0K
- STTK 101.1K
- Earning Date
- INTZ 04-29-2025
- STTK 07-31-2025
- Dividend Yield
- INTZ N/A
- STTK N/A
- EPS Growth
- INTZ N/A
- STTK N/A
- EPS
- INTZ N/A
- STTK N/A
- Revenue
- INTZ $6,415,000.00
- STTK $4,606,000.00
- Revenue This Year
- INTZ $35.18
- STTK N/A
- Revenue Next Year
- INTZ $32.43
- STTK N/A
- P/E Ratio
- INTZ N/A
- STTK N/A
- Revenue Growth
- INTZ 18.07
- STTK 69.65
- 52 Week Low
- INTZ $0.35
- STTK $0.69
- 52 Week High
- INTZ $7.34
- STTK $7.49
- Technical
- Relative Strength Index (RSI)
- INTZ 71.66
- STTK 56.02
- Support Level
- INTZ $1.28
- STTK $0.98
- Resistance Level
- INTZ $2.40
- STTK $1.13
- Average True Range (ATR)
- INTZ 0.18
- STTK 0.10
- MACD
- INTZ 0.05
- STTK 0.01
- Stochastic Oscillator
- INTZ 76.79
- STTK 84.85
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.